BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4346935)

  • 21. The nature of the resistance to methylene dimethane sulphonate in the Yoshida sarcoma.
    Fox BW; Fox M
    Br J Cancer; 1973 Jul; 28(1):81. PubMed ID: 4737505
    [No Abstract]   [Full Text] [Related]  

  • 22. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL; Momparler LF
    Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivo.
    Browman GP; Lazarus H
    Cancer Treat Rep; 1980; 64(2-3):231-6. PubMed ID: 7407755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cells.
    Schuette BP; Rabinovitz M; Vistica DT
    Cancer Lett; 1980 Feb; 8(4):335-41. PubMed ID: 6929219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical studies of a new antitumor agent, O2,2'-cyclocytidine.
    Ho DH
    Biochem Pharmacol; 1974 Apr; 23(8):1235-44. PubMed ID: 4824772
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F; Ueda K; Kawashima K; Jamshedur Rahman SM; Isobe K; Yoshida T; Hasegawa Y; Ando K; Iwamoto T; Nagura E
    J Immunol; 1987 Apr; 138(7):2359-65. PubMed ID: 2951438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of buffers and pH on in vitro binding of 67Ga by L1210 leukemic cells.
    Glickson JD; Webb J; Gams RA
    Cancer Res; 1974 Nov; 34(11):2957-60. PubMed ID: 4370802
    [No Abstract]   [Full Text] [Related]  

  • 31. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA; Otter GM; Chen CF
    Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells.
    Hromas RA; Andrews PA; Murphy MP; Burns CP
    Cancer Lett; 1987 Jan; 34(1):9-13. PubMed ID: 3802072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus).
    Takeyama H; Kawashima K; Yamada K; Ito Y
    Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA).
    Nicolin A; Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1973 Feb; 57(1):3-10. PubMed ID: 4704101
    [No Abstract]   [Full Text] [Related]  

  • 36. Depression of the platelet count after inoculation of mice with L1210 or L5178Y cells.
    Hacker M; Roberts D; Jackson C
    Br J Haematol; 1977 Mar; 35(3):465-71. PubMed ID: 857860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical properties and biological effects of 2-haloethyl sulfonates.
    Bowdon BJ; Wheeler GP; Adamson DJ; Shealy YF
    Biochem Pharmacol; 1984 Oct; 33(19):2951-6. PubMed ID: 6091664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on a cell line derived from the L1210 murine leukemia with altered surface properties and decreased capacity for tumor production.
    Kessel D; Bosmann HB
    Cancer Res; 1974 Mar; 34(3):603-8. PubMed ID: 4855835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.